Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
The Urologic Clinics of North America|April 18, 2025
Evaluation of the Adrenal Mass in Urologic PracticeJackson Schmidt, Marshall Strother
Journal of the American College of Radiology : JACR|September 17, 2013
Optimizing radiation use during fluoroscopic procedures: a quality and safety improvement projectJames R Duncan, Mandie Street, Marshall Strother, et al.
Urologic Oncology|February 21, 2023
Distinguishing lipid-poor angiomyolipoma from renal carcinoma using tumor shapeMarshall Strother, Robert N Uzzo, Elizabeth Handorf, et al.
Urology Case Reports|October 11, 2021
Multiple brain metastases in a patient with ypT0N0 micropapillary urothelial carcinoma of the bladderSrikar Kuppa, Jeffrey Wei, Marshall Strother, et al.
Urologic Oncology|December 14, 2020
Financial incentives and wearable activity monitors to increase ambulation after cystectomy: A randomized controlled trialMarshall Strother, Kristen Koepsell, Lihai Song, et al.
Journal of Endourology|December 28, 2013
In vivo evaluation of a reverse thermosensitive polymer for ureteroscopy with laser lithotripsy: porcine modelJonathan M Mobley, Goutham Vemana, Marshall Strother, et al.
The Journal of Urology|May 22, 2019
National Variation in Opioid Prescription Fills and Long-Term Use in Opioid Naïve Patients after Urological SurgeryIan Berger, Marshall Strother, Ruchika Talwar, et al.
The Journal of Urology|March 6, 2014
Modified Gleason grade of prostatic adenocarcinomas detected in the PLCO cancer screening trialPeter A Humphrey, Thomas P Hickey, Thomas L Riley, et al.
European Journal of Cancer (Oxford, England : 1990)|April 23, 2022
Pathological and genetic markers improve recurrence prognostication with the University of California Los Angeles Integrated Staging System for patients with clear cell renal cell carcinomaNils Kroeger, Cédric Lebacle, Justine Hein, et al.
American Journal of Clinical and Experimental Urology|October 31, 2022
Prognostic significance of sarcomatoid features in metastatic renal cell carcinoma treated with cytoreductive nephrectomy and targeted therapyBrian D Cortese, Raju Chelluri, Leilei Xia, et al.
Pageof 2